# Rat P2X7 Receptor Show Functional Independence Between Macropore Formation and Scavenger Activity

**Authors:** Javier Mena, Elías Leiva-Salcedo, Natalia Araya-Dapremont, Francisco Bravo-Cabezas, Ana Jane Villa, Geraldine Vivanco-Duarte, Ángel Mejía, Valentina Galarce-Keidong, Matías Lee, Francisca Espinola-Gonzalez, Nelly Nuñez-Rojas, Nayiberg Varas, Carolina Schäfer, Andrea Mella-Torres, Juan Pablo Huidobro-Toro, Kevin Maisey, Vivienne C Bachelet, Alejandro Escobar, Carlos Barrera-Avalos, Claudio Acuña-Castillo

PMC · DOI: 10.3390/ijms27041922 · International Journal of Molecular Sciences · 2026-02-17

## TL;DR

This study shows that the P2X7 receptor can still perform scavenger activity even when it loses its ability to form macropores or conduct ions.

## Contribution

The paper demonstrates functional independence between macropore formation and scavenger activity in P2X7 receptor variants.

## Key findings

- Macropore formation depends on channel conductance, contradicting prior reports on P2X7B.
- All tested variants impaired signaling pathway activation but retained scavenger activity.
- Loss of conductance or macropore function does not eliminate other P2X7 functions.

## Abstract

The purinergic ionotropic receptor P2X7 stands out from other members of the P2X family due to its ability to form a macropore, activate multiple intracellular signaling pathways, and, as more recently reported, to mediate scavenger activity toward apoptotic cells. In addition, P2X7 exhibits a high number of single nucleotide polymorphisms (SNPs) and splice variants, several of which have been shown to impair ATP-mediated macropore formation. The aim of this study was to determine whether specific SNPs or deletion variants that have lost channel conductance or macropore activity retain other reported P2X7 functions. To address this, we analyzed the following variants: P2X7A (wild-type), P2X7B (unable to activate the macropore), P2X7 T283M (lacking conductance and macropore formation), P2X7 with N-terminal deletion (∆N; deficient in signal transduction), and P2X7 DN (dominant-negative double mutant W167A/C168A, lacking all known activities). We evaluated calcium influx, macropore formation, ERK and p38 signaling, and scavenger activity. Our results indicate that macropore formation depends on channel conductance, in contrast to what has been previously reported for P2X7B. Moreover, all modifications tested impaired signaling pathway activation. Strikingly, none of the mutations affected receptor-mediated phagocytic activity. These findings suggest that loss of conductance or macropore formation does not necessarily entail loss of other P2X7 functions, and our data reveals a functional independence between scavenger activity and the canonical roles of P2X7 (channel/macropore, MAPKs). This modular view provides a framework to reconcile the apparently discordant phenotypes of P2X7 variants observed across diverse pathophysiological settings.

## Linked entities

- **Genes:** P2RX7 (purinergic receptor P2X 7) [NCBI Gene 5027]
- **Proteins:** EPHB2 (EPH receptor B2), CRK (CRK proto-oncogene, adaptor protein)

## Full-text entities

- **Genes:** RHO (rhodopsin) [NCBI Gene 6010] {aka CSNBAD1, OPN2, RP4}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, Ephb1 (Eph receptor B1) [NCBI Gene 24338] {aka Ephb2, Erk, elk}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, P2RX7 (purinergic receptor P2X 7) [NCBI Gene 5027] {aka P2X7}, PANX1 (pannexin 1) [NCBI Gene 24145] {aka MRS1, OOMD7, OZEMA7, PX1, UNQ2529}, Mapk14 (mitogen activated protein kinase 14) [NCBI Gene 81649] {aka CRK1, CSBP, CSPB1, Csbp1, Csbp2, Exip}, GPLD1 (glycosylphosphatidylinositol specific phospholipase D1) [NCBI Gene 2822] {aka GPIPLD, GPIPLDM, PIGPLD, PIGPLD1, PLD}
- **Diseases:** graft-versus-host disease (MESH:D006086), pulmonary and extrapulmonary tuberculosis (MESH:D000092225), cancer (MESH:D009369), Loss of Macropore Function (MESH:D006315), infection (MESH:D007239), cervical cancer (MESH:D002583), metastasis (MESH:D009362), inflammatory disease (MESH:D007249), injury to (MESH:D014947), sepsis (MESH:D018805), neuropathic pain (MESH:D009437)
- **Chemicals:** Triton X-100 (MESH:D017830), hygromycin (MESH:C026273), N (MESH:D009584), EtBr (MESH:D004996), ionomycin (MESH:D015759), APR-004 (-), Calcium (MESH:D002118), A740003 (MESH:C515928), acrylamide (MESH:D020106), SDS (MESH:D012967), CaCl2 (MESH:D002122), Fluo-4 (MESH:C409648), PBS (MESH:D007854), ATP (MESH:D000255), BzATP (MESH:C033901)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** M at position 283, W167A, C168A, W167A, E496A, C168A, T238M, T283M, T283M
- **Cell lines:** HEK — Homo sapiens (Human), Transformed cell line (CVCL_0045), HEK P2X7A — Homo sapiens (Human), Transformed cell line (CVCL_YJ33), MutuDC1940 — Homo sapiens (Human), Transformed cell line (CVCL_1W31)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940821/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940821/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940821/full.md

---
Source: https://tomesphere.com/paper/PMC12940821